Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06436300 · ClinicalTrials.gov registry record · NA
Colorectal Cancer Screening in Alaska Native Men
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 998
- Enrollment target
NCT06436300: Completed NA study, sponsored by Washington State University.
NCT06436300 is a NA study that has completed, run by Washington State University. The registered enrollment target is 998 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06436300, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 998 participants
- Enrollment target
Study Summary
Alaska Native men have the highest rates of colorectal cancer incidence and mortality in the US. Screening can prevent disease and improve survival. A previous study tested text messages to increase colorectal cancer screening in Alaska Native patients of the Southcentral Foundation healthcare system in Anchorage, Alaska. The intervention improved screening by 50% in women, but it had no effect in men. The current study aimed to culturally tailor the intervention for Alaska Native Men, and to test it with a randomized controlled trial among patients at the Southcentral Foundation.
Primary Outcome
Screening procedure documented in the electronic medical record
Interventions
- BEHAVIORAL Motivational text messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 998 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
What the finished NCT06436300 record still lists
NCT06436300 is an interventional study that assigns participants to a tested intervention. The registered 998 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 1 intervention - of which Motivational text messaging is the first listed.
NCT06436300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06436300 about?
NCT06436300 is a clinical study titled "Colorectal Cancer Screening in Alaska Native Men". Alaska Native men have the highest rates of colorectal cancer incidence and mortality in the US. Screening can prevent disease and improve survival. A previous study tested text messages to increase colorectal cancer screening in Alaska Native patients of the Southcentral Foundation healthcare syste...
What is the current status of trial NCT06436300?
This trial is currently completed. It is a NA study. The enrollment target is 998 participants. The study started on 2023-08-01. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT06436300?
The interventions under investigation include: Motivational text messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06436300?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06436300's enrollment target sits among peer trials
998 121st of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02986048 · 999 participants
Proton Therapy Patient Registry
- NCT04703244 · 999 participants
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI